|
KLF10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73556999999436E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.583100E-04 |
| Normal-vs-Stage2 |
4.978800E-04 |
| Normal-vs-Stage3 |
1.176040E-04 |
| Normal-vs-Stage4 |
9.67539999999767E-05 |
| Stage1-vs-Stage2 |
2.852000E-01 |
| Stage1-vs-Stage3 |
7.414400E-02 |
| Stage1-vs-Stage4 |
5.076000E-02 |
| Stage2-vs-Stage3 |
6.076800E-01 |
| Stage2-vs-Stage4 |
4.224000E-01 |
| Stage3-vs-Stage4 |
6.966400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39009999999373E-05 |
| Normal-vs-AfricanAmerican |
1.216120E-03 |
| Normal-vs-Asian |
9.208300E-02 |
| Caucasian-vs-AfricanAmerican |
6.700400E-01 |
| Caucasian-vs-Asian |
8.837400E-01 |
| AfricanAmerican-vs-Asian |
7.668000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.570700E-04 |
| Normal-vs-Female |
7.165800E-04 |
| Male-vs-Female |
9.464600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.443300E-04 |
| Normal-vs-Extreme_Weight |
8.974600E-04 |
| Normal-vs-Obese |
9.180500E-04 |
| Normal-vs-Extreme_Obese |
2.036000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.348200E-01 |
| Normal_Weight-vs-Obese |
6.661000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.476400E-01 |
| Extreme_Weight-vs-Obese |
6.279600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.467400E-01 |
| Obese-vs-Extreme_Obese |
6.327600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.099950E-02 |
| Normal-vs-Age(41-60Yrs) |
1.623260E-04 |
| Normal-vs-Age(61-80Yrs) |
3.87969999999793E-05 |
| Normal-vs-Age(81-100Yrs) |
6.311900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.756200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.970200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.538000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.183000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.382000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.944200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.281600E-03 |
| Normal-VS-Type2 PRCC |
4.3363000000074E-05 |
| Normal-VS-KIRP CIMP |
1.496390E-03 |
| Normal-VS-Unclassified PRCC |
4.369800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.248700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.104800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.645600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.275400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.309000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.887600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.000470E-04 |
| Normal-vs-N1 |
3.90900000000194E-05 |
| Normal-vs-N2 |
1.119030E-01 |
| N0-vs-N1 |
6.390600E-01 |
| N0-vs-N2 |
9.976400E-01 |
| N1-vs-N2 |
7.846400E-01 |
|
|
